Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Roblox
RBLX
|
$557M |
| 2 |
JPMorgan Chase
JPM
|
$497M |
| 3 |
Amazon
AMZN
|
$492M |
| 4 |
AT&T
T
|
$448M |
| 5 |
Coinbase
COIN
|
$338M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$893M |
| 2 |
Advanced Micro Devices
AMD
|
$706M |
| 3 |
Qualcomm
QCOM
|
$580M |
| 4 |
Adobe
ADBE
|
$542M |
| 5 |
Johnson & Johnson
JNJ
|
$455M |
Sector Composition
| 1 | Healthcare | 19.45% |
| 2 | Technology | 17.76% |
| 3 | Consumer Staples | 10.28% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Financials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Citigroup
C
$174B
| $282M | 0.35% |
+4,673,920
| New | +$282M |
|
52
Berkshire Hathaway Class B
BRK.B
$1.08T
| $281M | 0.35% |
941,300
+795,583
| +546% | +$238M |
|
53
AbbVie
ABBV
$374B
| $278M | 0.35% |
2,053,577
-17,317
| -0.8% | -$2.34M |
|
54
Palantir
PLTR
$373B
| $267M | 0.33% |
14,656,011
+1,696,483
| +13% | +$30.9M |
|
|
XYZ
55
Block, Inc.
XYZ
$46.5B
| $264M | 0.33% |
+1,632,832
| New | +$264M |
|
56
Biogen
BIIB
$20.5B
| $258M | 0.32% |
1,073,807
+92,100
| +9% | +$22.1M |
|
57
United Parcel Service
UPS
$72.2B
| $249M | 0.31% |
1,163,823
+309,123
| +36% | +$66.3M |
|
58
Amgen
AMGN
$154B
| $248M | 0.31% |
1,101,853
+950,008
| +626% | +$214M |
|
59
CSX Corp
CSX
$60B
| $246M | 0.31% |
6,539,873
+1,033,773
| +19% | +$38.9M |
|
60
Meta Platforms (Facebook)
META
$1.85T
| $246M | 0.31% |
730,700
+464,400
| +174% | +$156M |
|
|
HZNP
61
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $245M | 0.31% |
2,277,066
-974,397
| -30% | -$105M |
|
62
Bank of America
BAC
$373B
| $234M | 0.29% |
+5,270,066
| New | +$234M |
|
63
Procter & Gamble
PG
$370B
| $232M | 0.29% |
1,420,118
-278,405
| -16% | -$45.5M |
|
64
Quest Diagnostics
DGX
$20.3B
| $228M | 0.28% |
1,317,700
+350,400
| +36% | +$60.6M |
|
65
Clorox
CLX
$14.7B
| $224M | 0.28% |
1,287,130
-6,000
| -0.5% | -$1.05M |
|
66
Abbott
ABT
$229B
| $221M | 0.28% |
1,572,166
+1,337,000
| +569% | +$188M |
|
67
O'Reilly Automotive
ORLY
$87.6B
| $217M | 0.27% |
307,857
+42,663
| +16% | +$30.1M |
|
68
Jazz Pharmaceuticals
JAZZ
$7.75B
| $217M | 0.27% |
1,700,509
-298,500
| -15% | -$38M |
|
69
Southern Company
SO
$102B
| $211M | 0.26% |
3,074,011
+627,911
| +26% | +$43.1M |
|
70
Dropbox
DBX
$7.84B
| $207M | 0.26% |
8,446,333
-1,147,269
| -12% | -$28.2M |
|
71
GE Aerospace
GE
$292B
| $205M | 0.26% |
2,174,079
-245,678
| -10% | -$23.2M |
|
72
PepsiCo
PEP
$206B
| $198M | 0.25% |
1,141,062
-575,800
| -34% | -$100M |
|
73
Cable One
CABO
$909M
| $195M | 0.24% |
110,800
-17,400
| -14% | -$30.7M |
|
74
Colgate-Palmolive
CL
$67.9B
| $193M | 0.24% |
2,261,386
-1,146,695
| -34% | -$97.9M |
|
75
National Beverage
FIZZ
$3.94B
| $192M | 0.24% |
4,242,944
-71,600
| -2% | -$3.25M |
|